Page last updated: 2024-08-22

betamethasone-17,21-dipropionate and Pyoderma

betamethasone-17,21-dipropionate has been researched along with Pyoderma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barrick, CJ; Ermolovich, T; Lountzis, NI; Onikoyi, O; Purcell, SM1
Desai, A; Janaki, VR; Mittal, RR; Savant, S; Sengupta, S1

Other Studies

2 other study(ies) available for betamethasone-17,21-dipropionate and Pyoderma

ArticleYear
Necrobiosis lipoidica with superimposed pyoderma vegetans.
    Cutis, 2019, Volume: 103, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Betamethasone; Cephalexin; Female; Humans; Mupirocin; Necrobiosis Lipoidica; Pyoderma; Skin Diseases, Bacterial

2019
Evaluation of safety and efficacy of supirocin-B (mupirocin 2% + betamethasone dipropionate 0.05%) in infected dermatoses--a post marketing study.
    Journal of the Indian Medical Association, 2000, Volume: 98, Issue:4

    Topics: Betamethasone; Drug Combinations; Humans; India; Mupirocin; Ointments; Product Surveillance, Postmarketing; Pyoderma; Staphylococcal Skin Infections; Streptococcal Infections; Treatment Outcome

2000